If you suffer from allergies, you know how bothersome and uncomfortable the sneezing and itchy eyes can be. These symptoms are more than irritating — they impact day-to-day activities like work, school, sports, sleeping and even eating. Not only that, but allergies can also cause more serious health problems such as asthma and even anaphylaxis,…  read on >  read on >

Poor sleep brought on by sleep apnea may ultimately undermine the brain health of older men and women, new research suggests. The concern stems from a new brain scan investigation that involved 140 sleep apnea patients. “Sleep apnea is a medical condition in which patients … stop breathing during sleep, which can affect their sleep…  read on >  read on >

While the U.S. Veterans Affairs health system has been criticized for long appointment wait times and limited access to specialists, the quality of care and access to a range of surgical services is as good as or better than at non-VA health centers on several measures, new research reveals. “Surgery involves many steps of care,”…  read on >  read on >

A study of triathletes reveals certain body types perform better in certain climates. Taller, leaner runners with long limbs tend to excel in Ironman endurance events held in warm climates, whereas marathoners with stockier builds and shorter limbs perform better in colder climates, a Dartmouth College researcher says. Endurance athletes may want to consider competing…  read on >  read on >

Cats who became infected with COVID-19 had the same variants as their owners throughout the different phases of the pandemic, new research finds. Scientists looked at retrospective samples to assess COVID-19 infections in U.K. cats from April 2020 to February 2022. The cats had been infected with the Alpha and Delta variants following their emergence…  read on >  read on >

Researchers have isolated for the first time a free-floating form of amyloid beta that appears to be a key driver of Alzheimer’s disease. Further, they argue that a newly approved Alzheimer’s drug — lecanemab (Leqembi) — directly targets these small, complex chains of amyloid beta (A-beta) called fibrils. The U.S. Food and Drug Administration approved…  read on >  read on >